Intelligent Bio Solutions Statistics
Total Valuation
INBS has a market cap or net worth of $8.28 million. The enterprise value is $6.66 million.
Important Dates
The next estimated earnings date is Tuesday, May 20, 2025, before market open.
| Earnings Date | May 20, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
INBS has 6.78 million shares outstanding. The number of shares has increased by 912.24% in one year.
| Current Share Class | 6.78M |
| Shares Outstanding | 6.78M |
| Shares Change (YoY) | +912.24% |
| Shares Change (QoQ) | +19.02% |
| Owned by Insiders (%) | 1.40% |
| Owned by Institutions (%) | 7.97% |
| Float | 6.07M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.37 |
| Forward PS | 0.45 |
| PB Ratio | 1.34 |
| P/TBV Ratio | 17.86 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.20 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.92, with a Debt / Equity ratio of 0.15.
| Current Ratio | 0.92 |
| Quick Ratio | 0.66 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -80.83 |
Financial Efficiency
Return on equity (ROE) is -291.77% and return on invested capital (ROIC) is -148.31%.
| Return on Equity (ROE) | -291.77% |
| Return on Assets (ROA) | -76.77% |
| Return on Invested Capital (ROIC) | -148.31% |
| Return on Capital Employed (ROCE) | -251.22% |
| Revenue Per Employee | $60,628 |
| Profits Per Employee | -$213,940 |
| Employee Count | 50 |
| Asset Turnover | 0.35 |
| Inventory Turnover | 1.79 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -47.86% in the last 52 weeks. The beta is 4.63, so INBS's price volatility has been higher than the market average.
| Beta (5Y) | 4.63 |
| 52-Week Price Change | -47.86% |
| 50-Day Moving Average | 1.59 |
| 200-Day Moving Average | 1.58 |
| Relative Strength Index (RSI) | 40.61 |
| Average Volume (20 Days) | 69,093 |
Short Selling Information
The latest short interest is 533,974, so 7.87% of the outstanding shares have been sold short.
| Short Interest | 533,974 |
| Short Previous Month | 541,819 |
| Short % of Shares Out | 7.87% |
| Short % of Float | 8.80% |
| Short Ratio (days to cover) | 4.52 |
Income Statement
In the last 12 months, INBS had revenue of $3.03 million and -$10.70 million in losses. Loss per share was -$3.15.
| Revenue | 3.03M |
| Gross Profit | 1.56M |
| Operating Income | -10.76M |
| Pretax Income | -10.03M |
| Net Income | -10.70M |
| EBITDA | -9.77M |
| EBIT | -10.76M |
| Loss Per Share | -$3.15 |
Full Income StatementBalance Sheet
The company has $2.24 million in cash and $626,015 in debt, giving a net cash position of $1.62 million or $0.24 per share.
| Cash & Cash Equivalents | 2.24M |
| Total Debt | 626,015 |
| Net Cash | 1.62M |
| Net Cash Per Share | $0.24 |
| Equity (Book Value) | 4.20M |
| Book Value Per Share | 0.91 |
| Working Capital | -341,243 |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$10.10 million and capital expenditures -$173,693, giving a free cash flow of -$10.28 million.
| Operating Cash Flow | -10.10M |
| Capital Expenditures | -173,693 |
| Free Cash Flow | -10.28M |
| FCF Per Share | -$1.51 |
Full Cash Flow StatementMargins
| Gross Margin | 51.59% |
| Operating Margin | -354.79% |
| Pretax Margin | -354.08% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |